The first patent family
Definition of promoter and some of its elements
In the first patent family, promoters are defined in functional and structural terms. They are described as the transcription control units that contain the signals for RNA polymerase to begin transcription so that protein synthesis can occur. Promoters are located in the 5′ flanking or upstream region of the transcribed gene. The most common motifs present in promoters are:
- the TATA element, which is the site where the TATA-binding protein (TBP) binds. This protein is part of a complex of polypeptides that recruit RNA polymerase II to begin transcription;
- the transcription start site; and
- the CCAAT consensus sequence.
A core promoter or minimal promoter contains the TATA box and the transcription start site. This core promoter may or may not have detectable activity in the absence of sequence(s) that enhance this activity or confer tissue- specific activity.
Other elements of promoter regions include:
- INR, sequences near the transcription start site of some genes that provide an alternate site for binding factors to activate transcription;
- enhancers; and
- upstream elements.
The enhancers are not classified as upstream elements by the inventors. The upstream elements disclosed, unlike enhancers, are position and orientation dependent, interact with specific binding factors and are less common. The upstream elements also may be exchanged with other elements while maintaining their characteristic control over gene expression. In contrast, enhancers can increase the efficiency of transcription regardless of their distance and orientation to the transcription start site.
Approximate scope of protection
The synthetic promoters that are the subject of the Pioneer Hi-Bred’s inventions contain:
- a TATA motif;
- a GC-rich region (at least 64% GC); and
- a transcription start site.
According to the inventors, the GC-rich region located between the TATA motif and the transcription start site in plant promoters acts as a very strong inducer of constitutive expression. It increases transcriptional activation efficiency. Plant-expressible promoters contain a region of about 40% GC, while a 64% or greater GC content is characteristic of animal promoters. The maize ubiquitin 1 gene (Ubi-1) core promoter, which produces high levels of activity in monocots, has a GC content more similar to animal promoters (64%). The GC content of promoters covered by the claims is at least 64%.
Both the U.S. and the Australian patents claim a synthetic promoter as described. Expression cassettes containing a structural gene linked to the promoter and a poly(A) signal are also part of the claimed inventions.
In addition, both patents claim:
- A synthetic upstream element comprising at least 3 octopine synthase (OCS) binding motifs (TGACG) with an intervening sequence. This motif has been identified from several opine synthase genes, i.e., octopine, nopaline, mannopine, and from other genes such as histone genes.
- Expression cassettes containing the synthetic upstream element linked to the synthetic promoter.
- Expression cassettes where the synthetic upstream element is linked to a promoter which does not necessarily have the structural elements described above.
The U.S. patent also claims a promoter construct having a core promoter and the upstream activating region (UAR) of the Ubi-1 gene. An expression cassette containing these elements, a structural gene linked to the promoter and a poly(A) signal is also claimed.
A summary of the independent claims of the granted patents and some bibliographic data are shown in the following table.
Patent number |
Title, Independent Claims and Summary of Claims |
Assignee |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Title – Synthetic promoters
The claims are directed to:
According to the specification, 64% or greater GC content from TATA to start of transcription is generally characteristic of animal promoters. Thus, claims 1-5 are potentially targeting the use of animal promoters in plant systems. ‘Having’ in claim 7 is ambiguous; would an infringing sequence contain only this, or this and other elements? The isolated nucleotide sequence as an enhancer in claim 13 can have nucleotides in addition to the TGACG motif. Using bigger sequences containing TGACG could still infrige the claim. The Ubi-1 UAR (upstream activating region) claimed in claims 14 and 15 comprises the sequence disclosed in SEQ ID No:13. The Ubi-1 UAR can be used in both directions and in multiple copies. However, the Ubi-1 UAR sequence disclosed here is 813 bp and use only portions of the sequence would not be covered by these claims. |
Pioneer Hi-Bred International Inc. |
|||||||||||||||
US 6555673
|
Title – Synthetic promoters
This patent is a Continuation of US 6072050. The claims are drawn to: 1. Promoter constructs comprise:
2. Promoter constructs comprising any of the following sequences: SCP1 promoter, SEQ ID NO:12; UCP1 promoter, SEQ ID NO:15; UCP2 promoter, SEQ ID NO:16; UCP3 promoter, SEQ ID NO:17 and UCP4 promoter, SEQ ID NO:18). (see claims 19-23) 3. A promoter construct comprising a sequence having at least 95% sequence identity to the portion of the SCP1 promoter, which is not a CaMV 35S UAR sequence. This promoter can direct higher transcription than a promoter consisting of the synthetic core promoter sequence (SEQ ID NO:1) (see claim 24). 4. A promoter construct comprising a sequence having at least 95% sequence identity to the portion of one of the promoters: UCP1 promoter, UCP2 promoter, UCP3 promoter, and UCP4 promoter, which is not a Ubi-1 UAR sequence.These promoters can direct higher transcription than a promoter consisting of the synthetic core promoter sequence (SEQ ID NO:1) (see claims 25-28). This patent claims promoter constructs comprising all the claim elements in US 6072050. In addition, promoters with at least 95% identity to the portion of promoters SCP1 (35S UAR linked to core promoter of SEQ ID NO: 1), UCP1 (one copy of Ubi1 UAR linked with the core promoter), UCP2 (2 copies of Ubi1 UAR linked with the core promoter), UCP3 (3 copies of Ubi1 UAR linked with the core promoter) and UCP4 (4 copies of Ubi1 UAR linked with the core promoter) are also covered. According to the specification, upstream activating region (UAR) is typically a position or orientation dependent element that primarily directs tissue, cell type, or regulated expression. The UAR in claims 1 and 14 is not restricted to Ubi-1 UAR and CaMV 35S UAR and therefore could be from any organism. |
||||||||||||||||
AU 751402 B2
|
Title – Synthetic promoters
The Australian patent claims cover all the claim elements for the synthetic promoters, the upstream element and the UARs as claimed in US 6555673. Addition to these, it also claims for a method for controlling the level of expression of a transgenic nucleotide sequence in dicotyledonous plant cells comprising transforming a plant cell with an expression cassette comprising a synthetic promoter comprising the above claim elements. |
||||||||||||||||
Remarks |
Related applications are pending in Europe (EP 1056875) and Canada (CA 2314598). A patent was also granted in New Zealand (NZ 506182). | ||||||||||||||||
AU 729929 B2
|
Title – A synthetic plant core promoter and upstream regulatory element
The claims are related to:
The claims for the synthetic promoter in this Australian patent is very broad as comparing to the related US and Canadian patents. |
||||||||||||||||
EP 914454B1
|
Title – A synthetic plant core promoter and upstream regulatory element
|
||||||||||||||||
CA 2257719
|
Title – A synthetic plant core promoter and upstream regulatory element
|
||||||||||||||||
Remarks |
Application also filed in Brazil (BR 9710690 A) |